Literature DB >> 27521030

[Radiotherapy of bladder cancer].

O Riou1, B Chauvet2, J-L Lagrange3, P Martin4, C Llacer Moscardo5, M Charissoux5, O Lauche5, N Aillères5, P Fenoglietto5, D Azria5.   

Abstract

Surgery (radical cystectomy) is the standard treatment of muscle-invasive bladder cancer. Radiochemotherapy has risen as an alternative treatment option to surgery as part as organ-sparing combined modality treatment or for patients unfit for surgery. Radiochemotherapy achieves 5-year bladder intact survival of 40 to 65% and 5-year overall survival of 40 to 50% with excellent quality of life. This article introduces the French recommendations for radiotherapy of bladder cancer: indications, exams, technique, dosimetry, delivery and image guidance.
Copyright © 2016 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Cancer de vessie; Radiotherapy; Radiothérapie; Recommandations; Recommendations

Mesh:

Year:  2016        PMID: 27521030     DOI: 10.1016/j.canrad.2016.07.010

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  1 in total

1.  Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer.

Authors:  Alexander Schulz; Ielizaveta Gorodetska; Rayk Behrendt; Susanne Fuessel; Kati Erdmann; Sarah Foerster; Kaustubh Datta; Thomas Mayr; Anna Dubrovska; Michael H Muders
Journal:  Front Oncol       Date:  2020-01-21       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.